Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity

被引:10
|
作者
Diwan, A. Hafeez [1 ]
Skelton, Henry G., III [2 ]
Horenstein, Marcelo G. [3 ]
Kelly, David R. [4 ]
Barrett, Terry L. [5 ]
Bussian, Anne H. [7 ]
Sanders, Deborah Y. [6 ]
Lazar, Alexander J. F. [1 ]
Prieto, Victor G. [1 ]
Smith, Kathleen J. [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Quest Diagnost, Tucker, GA USA
[3] Univ S Alabama, Dept Pathol, Mobile, AL 36688 USA
[4] Childrens Hosp, Dept Pathol, Birmingham, AL USA
[5] Propath, Dallas, TX USA
[6] Serv Dermatopathol, Birmingham, AL USA
[7] Skin Pathol Associates, Birmingham, AL USA
关键词
D O I
10.1111/j.1600-0560.2007.00872.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
According to most authors, dermatofibrosarcoma protuberans (DFSP) and giant cell fibroblastoma (GCF) represent the adult and juvenile forms, respectively, of the same disease entity, as evidenced by similar morphology, an identical chromosomal translocation, and CD34 positivity. It has been shown that DFSP and nuchal-type fibroma (NTF) (which is also CD34-positive) are related lesions, and that there might possibly be a continuum between the two. In addition, NTF exhibits CD99 positivity. It was therefore, hypothesized that both DFSP and GCF would show similar immunopositivity for CD99. Archives of pathology at several institutions were searched for DFSP and GCF tissue blocks. A total of 29 DFSP and 5 GCF were analyzed by immunohistochemistry for expression of CD99. Twenty-three of 29 DFSP (79%) and 2 of 5 GCP (40%) expressed CD99. Comparison of CD99 and CD34 showed that the non-tumoral periphery of DFSP was less probable to be CD99 positive, but this finding was not statistically significant.
引用
收藏
页码:647 / 650
页数:4
相关论文
共 50 条
  • [31] A case of dermatofibrosarcoma protuberans with a COL1A1/PDGFB fusion identical to a case of giant cell fibroblastoma.
    Vanni, R
    O'Brien, KP
    Dettori, T
    Melis, GB
    Dumanski, JP
    Faa, G
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 132 - 133
  • [32] CD34 POSITIVITY IN FIBROSARCOMAS WHICH ARISE IN DERMATOFIBROSARCOMA PROTUBERANS
    GOLDBLUM, JR
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1995, 119 (03) : 238 - 241
  • [33] 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity
    Robertson, PB
    Neiman, RS
    Worapongpaiboon, S
    John, K
    Orazi, A
    MODERN PATHOLOGY, 1997, 10 (04) : 277 - 282
  • [34] A case of dermatofibrosarcoma protuberans of the vulva with a COL1A1/PDGFB fusion identical to a case of giant cell fibroblastoma
    R. Vanni
    Gavino Faa
    Tinuccia Dettori
    Gian B. Melis
    Jan P. Dumanski
    Kevin P. O’Brien
    Virchows Archiv, 2000, 437 : 95 - 100
  • [35] A new type of specific gene fusion generated by the t(17;22) associated to dermatofibrosarcoma protuberans and giant cell fibroblastoma.
    Simon, MP
    Pedeutour, F
    Sirvent, N
    Grosgeorge, J
    Minoletti, F
    Coindre, JM
    TerrierLacombe, MJ
    Mandahl, N
    Craver, RD
    Blin, N
    Sozzi, G
    TurcCarel, C
    OBrien, KP
    Kedra, D
    Fransson, I
    Guilbaud, C
    Dumanski, JP
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (05) : C33 - C33
  • [36] Giant cell fibroblastoma recurring as dermatofibrosarcoma. A pediatric case report
    Cherradi, N
    Malihy, A
    Benkiran, L
    Barahioui, M
    Alhamany, Z
    ANNALES DE PATHOLOGIE, 2002, 22 (06) : 465 - 468
  • [37] Giant cell fibroblastoma: A variant of dermatofibrosarcoma protruberans treated with Mohs' micrographic surgery
    Cook, JL
    DERMATOLOGIC SURGERY, 1999, 25 (06) : 509 - 512
  • [38] Genomic gains of COL1A1-PDGFB occur in the evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans:: A study of 13 cases with morphologic correlations
    Macarenco, R. S.
    Erickson-Johnson, M. R.
    Wang, X.
    Zamolyi, R.
    Nascimento, A. G.
    Oliveira, A. M.
    MODERN PATHOLOGY, 2007, 20 : 96A - 96A
  • [39] A role for CD99 in T cell activation
    Wingett, D
    Forcier, K
    Nielson, CP
    CELLULAR IMMUNOLOGY, 1999, 193 (01) : 17 - 23
  • [40] CD99 role in glioblastoma cell migration
    Cardoso, Cavalca
    Lerario, Antonio Marcondes
    de Carvalho Brantis, Carlos Eduardo
    Freitas, Vanessa Galdeno
    Soares, Roseli da Silva
    Nagahashi Marie, Suely Kazue
    Oba-Shinjo, Sueli Mieko
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 59 - 59